Long‐term leukoencephalopathy and neurocognitive functioning in childhood sarcoma patients treated with high‐dose intravenous chemotherapy
- 5 July 2019
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (10) , e27893
Abstract
Purpose: Knowledge is limited regarding the prevalence and persistence of chemotherapy‐induced leukoencephalopathy in childhood sarcoma patients. This study explored the presence, clinical relevance, and potential risk factors of leukoencephalopathy in childhood bone and soft tissue sarcoma survivors, treated with intravenous chemotherapy.Methods: We acquired cross‐sectional neurocognitive data in adult survivors (n = 34) (median age at diagnosis [AaD] = 13.32 years, age range = 16‐35 years) and healthy age‐matched controls (n = 34). Additionally, magnetic resonance imaging included T2‐weighted FLAIR (leukoencephalopathy Fazekas rating), multiexponential T2 relaxation (MET2), and multishell diffusion MRI to estimate myelin integrity‐related metrics and fluid movement restrictions. Finally, chemotherapy subgroups (methotrexate, alkylating agents, or combination), AaD, and Apoε and MTHFRC677T polymorphisms were explored as potential risk factors for leukoencephalopathy.Results: At the group level, quality of life, working memory, processing speed, and visual memory were significantly lower in patients compared to controls. Furthermore, long‐term leukoencephalopathy was observed in 27.2% of the childhood sarcoma survivors, which was related to attentional processing speed. Lesions were related to diffusion‐derived, but not to myelin‐sensitive metrics. A significant interaction effect between AaD and chemotherapy group demonstrated more lesions in case of high‐dose methotrexate (HD‐MTX) (F = 3.434, P = .047). However, patients treated with alkylating agents (without HD‐MTX) also showed lesions in younger patients. Genetic predictors were nonsignificant.Conclusion and implication: This study suggests long‐term leukoencephalopathy with possibly underlying changes in vasculature, inflammation, or axonal injury, but not necessarily long‐term demyelination. Such lesions could affect processing speed, and as such long‐term daily life functioning of these patients.Keywords
This publication has 50 references indexed in Scilit:
- Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 StudyJournal of Clinical Oncology, 2012
- Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive ImpairmentStroke, 2011
- Diffusion tensor imaging and beyondMagnetic Resonance in Medicine, 2011
- Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patientsHuman Brain Mapping, 2011
- Socioeconomic status and the brain: mechanistic insights from human and animal researchNature Reviews Neuroscience, 2010
- The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysisBMJ, 2010
- Socioeconomic status and the developing brainTrends in Cognitive Sciences, 2009
- Candidate mechanisms for chemotherapy-induced cognitive changesNature Reviews Cancer, 2007
- Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in childrenLeukemia, 2006
- The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapyPsycho-Oncology, 2003